209 related articles for article (PubMed ID: 18220516)
1. Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease.
Mahley RW; Huang Y; Weisgraber KH
Curr Alzheimer Res; 2007 Dec; 4(5):537-40. PubMed ID: 18220516
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.
Mahley RW; Weisgraber KH; Huang Y
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5644-51. PubMed ID: 16567625
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology.
Mahley RW; Huang Y
Acta Neurol Scand Suppl; 2006; 185():8-14. PubMed ID: 16866905
[TBL] [Abstract][Full Text] [Related]
4. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies.
Huang Y
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):627-41. PubMed ID: 17002223
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3.
Sanan DA; Weisgraber KH; Russell SJ; Mahley RW; Huang D; Saunders A; Schmechel D; Wisniewski T; Frangione B; Roses AD
J Clin Invest; 1994 Aug; 94(2):860-9. PubMed ID: 8040342
[TBL] [Abstract][Full Text] [Related]
6. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.
Buttini M; Yu GQ; Shockley K; Huang Y; Jones B; Masliah E; Mallory M; Yeo T; Longo FM; Mucke L
J Neurosci; 2002 Dec; 22(24):10539-48. PubMed ID: 12486146
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease.
Mahley RW; Nathan BP; Pitas RE
Ann N Y Acad Sci; 1996 Jan; 777():139-45. PubMed ID: 8624076
[TBL] [Abstract][Full Text] [Related]
9. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
10. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.
Buttini M; Orth M; Bellosta S; Akeefe H; Pitas RE; Wyss-Coray T; Mucke L; Mahley RW
J Neurosci; 1999 Jun; 19(12):4867-80. PubMed ID: 10366621
[TBL] [Abstract][Full Text] [Related]
11. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
12. Molecular Insight into the Therapeutic Promise of Targeting
Mamun AA; Uddin MS; Bin Bashar MF; Zaman S; Begum Y; Bulbul IJ; Islam MS; Sarwar MS; Mathew B; Amran MS; Md Ashraf G; Bin-Jumah MN; Mousa SA; Abdel-Daim MM
Oxid Med Cell Longev; 2020; 2020():5086250. PubMed ID: 32509144
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease: unraveling APOE4 binding to amyloid-beta peptide and lipids with molecular dynamics and quantum mechanics.
Gillet JN
J Biomol Struct Dyn; 2021 Sep; 39(14):5026-5032. PubMed ID: 32580638
[TBL] [Abstract][Full Text] [Related]
14. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
[TBL] [Abstract][Full Text] [Related]
15. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease.
Huang Y
Trends Mol Med; 2010 Jun; 16(6):287-94. PubMed ID: 20537952
[TBL] [Abstract][Full Text] [Related]
16. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
Huang Y
Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
[TBL] [Abstract][Full Text] [Related]
17. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
Levi O; Dolev I; Belinson H; Michaelson DM
J Neurochem; 2007 Nov; 103(3):1031-40. PubMed ID: 17666042
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target.
Ye S; Huang Y; Müllendorff K; Dong L; Giedt G; Meng EC; Cohen FE; Kuntz ID; Weisgraber KH; Mahley RW
Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18700-5. PubMed ID: 16344478
[TBL] [Abstract][Full Text] [Related]
20. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
